Post-transduction events in retrovirus-mediated gene therapy involving hematopoietic stem cells: Beyond efficiency issues

Journal of Cellular Biochemistry

Volumn 85, Issue , 2002, Pages 46-54

  Medin, Jeffrey A ^a,b   Fowler, Daniel H ^c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Gene therapy; Hematopoietic stem cells; Immunotherapy; Preselection; Retrovirus; Th1 Th2

Indexed keywords

ARTICLE; GENE THERAPY; GENE TRANSFER; HEMATOPOIETIC STEM CELL; IMMUNOTHERAPY; PRIORITY JOURNAL; RETROVIRUS; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; ANIMAL; COMBINED IMMUNODEFICIENCY; GENETIC TRANSDUCTION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; REVIEW;

UNIDENTIFIED RETROVIRUS;

ANIMALS; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; RETROVIRIDAE; SEVERE COMBINED IMMUNODEFICIENCY; TRANSDUCTION, GENETIC;

EID: 37649026220     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10052     Document Type: Article

References (40)

1. Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells
2. Isolation of putative progenitor endothelial cells for angiogenesis
3. T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years
4. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients
5. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
6. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice
7. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
8. Generation of polarized antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles
9. Allospecific CD4+, Th1/Th2 and CD8+, Tc1/Tc2 populations in murine GVL: Type I cells generate gv1, type II cells abrogate GVL
10. Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells
11. Preselection of retrovirally transduced bone marrow avoids subsequent stem cell gene silencing and age-dependent extinction of expression of human beta-globin in engrafted mice
12. Treatment of genetic defects in hematopoietic cell function by gene transfer
13. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency
14. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells
15. Virus treatment questioned after gene therapy death
16. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity
17. Viral vectors for gene therapy of hematopoietic cells
18. Selection of retrovirally transduced cells to enhance the efficiency of gene therapy
19. Dendritic cells engineered to express prostate-specific antigens for immunotherapy of prostate cancer
20. Plasticity of bone marrow-derived stem cells
21. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
22. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
23. Pharmacologically regulated cell therapy
24. Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy
25. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors
26. Gene transfer into human lymphocytes by a defective human immunodeficiency virus type I vector
27. Preselective gene therapy for Fabry disease
28. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene
29. Lymphokine production by human T cells in disease states
30. Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction
31. Human gene marker/therapy clinical protocols
32. Role of T-cell derived cytokines in the down-regulation of immune responses in parasitic and retroviral infection
33. Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficincy virus retroviral vector
34. Gene therapy for Fabry disease
35. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1
36. Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells
37. Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size
38. Progress in the use of gene transfer methods to treat genetic blood diseases
39. Partial phenotypic correction of human Lesch-Nyhan (hypoxanthine-guanine phosphoribosyltransferase-deficient) lymphoblasts with a transmissible retroviral vector
40. A selective amplifier gene for tamoxifeninducible expansion of hematopoietic cells